Plus Therapeutics (PSTV) Misses Q4 EPS by 424c
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
